Adjunctive therapy with low molecular weight heparin with recombinant tissue-type plasminogen activator causes sustained reflow in canine coronary thrombosis
Authors:
- Wilmer W. NicholsWNWilmer W. Nichols
- Tom G.P. SaldeenTSTom G.P. Saldeen
- Saeed KhanSKSaeed Khan
- Jawahar L. MehtaJMJawahar L. Mehta
- 1 August 1992
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 124 (2) , 280-288
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosisCardiovascular Research, 1991
- Guidelines for the early management of patients with acute myocardial infarctionJACC, 1990
- Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in RabbitsaAnnals of the New York Academy of Sciences, 1989
- RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2The Lancet, 1988
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Thromboxane synthetase inhibition with CGS 13080 improves coronary blood flow after streptokinase-induced thrombolysisAmerican Heart Journal, 1987
- Coronary Angioscopy in Patients with Unstable Angina PectorisNew England Journal of Medicine, 1986
- Frequency of intracoronary filling defects by angiography in Angina pectoris at restThe American Journal of Cardiology, 1985
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation, 1985